Clinical Trials Directory

Trials / Recruiting

RecruitingNCT03559569

Impact of Endothelial and Leukocyte Senescence in Circulatory Shock States

Status
Recruiting
Phase
Study type
Observational
Enrollment
520 (estimated)
Sponsor
University Hospital, Strasbourg, France · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Circulatory shocks (CS) are life-threatening, acute organ dysfunction. Advances in critical care medicine have decreased early hospital mortality, increasing the number of surviving patients. Regrettably, these survivors are at increased risk of new infections but also of cardiovascular disease. The investigators hypothesize that CS with multi-organ dysfunction is associated with premature senescence of endothelial cells and immune cells and promotes endothelial thrombogenicity and immunosenescence leading to cardiovascular disease and secondary infections. The aim of this work is therefore to evaluate the contribution of endothelial and leucocytes senescence to the occurrence of secondary events (infectious and cardiovascular) in patients with a CS. It will provide a better understanding of the pathogenesis of cardiovascular and immune diseases following a CS, likely to guide new management strategies to prevent their occurrence.

Conditions

Interventions

TypeNameDescription
BIOLOGICALBiological samples will be done to evaluate the endothelial and leukocyte senescence.Noninvasive, reproducible, and sensitive methods to measure cardiac function, endothelial function, and arterial stiffness will be assess.

Timeline

Start date
2019-01-07
Primary completion
2028-02-01
Completion
2028-03-01
First posted
2018-06-18
Last updated
2025-03-10

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT03559569. Inclusion in this directory is not an endorsement.